Link between disease status at 24 months and mortality in follicular lymphoma

Br J Haematol. 2022 Nov;199(3):458-462. doi: 10.1111/bjh.18423. Epub 2022 Aug 26.

Aino Rajamäki^{1

2}, Mika Hujo³, Reijo Sund², Roosa E I Prusila⁴, Milla E L Kuusisto^{4

5}, Hanne Kuitunen⁶, Esa Jantunen^{2

7}, Santiago Mercadal⁸, Marc Sorigue⁹, Juan-Manuel Sancho⁹, Outi Kuittinen^{2

4

10}, Kaisa Sunela¹¹

¹ Department of Oncology, Hospital Nova of Central Finland, Jyväskylä, Finland.
² Institute of Clinical Medicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.
³ School of Computing, Faculty of Science and Forestry, University of Eastern Finland, Kuopio, Finland.
⁴ Medical Research Center and Cancer and Translational Research Unit, University of Oulu and Oulu University Hospital, Oulu, Finland.
⁵ Department of Hematology, Oulu University Hospital, Oulu, Finland.
⁶ Department of Oncology, Oulu University Hospital, Oulu, Finland.
⁷ Department of Medicine, Kuopio University Hospital, Kuopio, Finland.
⁸ ICO-Hospital Duran I Reynals, L'Hospitalet, Spain.
⁹ Department of Hematology, ICO-Hospital Germans Trias i Pujol, IJC, UAB, Barcelona, Spain.
¹⁰ Department of Oncology, Kuopio University Hospital, Kuopio, Finland.
¹¹ Department of Oncology, Tays Cancer Center, Tampere University Hospital, Tampere, Finland.

No abstract available

Keywords: POD24; cause of death; event-free survival; follicular lymphoma; mortality; progression of disease.

Publication types